ATE216586T1 - Hirudin enthaltende arzneimittel - Google Patents

Hirudin enthaltende arzneimittel

Info

Publication number
ATE216586T1
ATE216586T1 AT94301083T AT94301083T ATE216586T1 AT E216586 T1 ATE216586 T1 AT E216586T1 AT 94301083 T AT94301083 T AT 94301083T AT 94301083 T AT94301083 T AT 94301083T AT E216586 T1 ATE216586 T1 AT E216586T1
Authority
AT
Austria
Prior art keywords
products containing
medicinal products
containing hirudin
hirudin
water
Prior art date
Application number
AT94301083T
Other languages
German (de)
English (en)
Inventor
Tudor Arvinte
Original Assignee
Novartis Ag
Ucp Gen Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Ucp Gen Pharma Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of ATE216586T1 publication Critical patent/ATE216586T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/57Protease inhibitors from animals; from humans
    • A61K38/58Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT94301083T 1993-02-18 1994-02-15 Hirudin enthaltende arzneimittel ATE216586T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939303275A GB9303275D0 (en) 1993-02-18 1993-02-18 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE216586T1 true ATE216586T1 (de) 2002-05-15

Family

ID=10730651

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94301083T ATE216586T1 (de) 1993-02-18 1994-02-15 Hirudin enthaltende arzneimittel

Country Status (21)

Country Link
US (1) US5472938A (h)
EP (1) EP0624375B1 (h)
JP (1) JP3649343B2 (h)
CN (1) CN1108137A (h)
AT (1) ATE216586T1 (h)
AU (1) AU675471B2 (h)
CA (1) CA2115815A1 (h)
DE (1) DE69430458T2 (h)
DK (1) DK0624375T3 (h)
ES (1) ES2176222T3 (h)
FI (1) FI940726A7 (h)
GB (1) GB9303275D0 (h)
HU (1) HUT66079A (h)
IL (1) IL108610A (h)
MX (1) MX9401244A (h)
NO (1) NO940551D0 (h)
NZ (1) NZ250895A (h)
PH (1) PH30338A (h)
PT (1) PT624375E (h)
TW (1) TW315303B (h)
ZA (1) ZA941087B (h)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401448D0 (en) * 1994-01-26 1994-03-23 Ciba Geigy Ag Stable dry powders
GB9401447D0 (en) 1994-01-26 1994-03-23 Ciba Geigy Ag Pharmaceutical compositions
US5510330A (en) * 1994-03-25 1996-04-23 Boehringer Mannheim Gmbh Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof.
EP0998942A4 (en) * 1997-01-20 2006-08-16 Japan Energy Corp METHOD FOR STABILIZING PEPTIDES AND FREEZERED MEDICINAL COMPOSITIONS THEREOF
RU2141326C1 (ru) * 1997-04-17 1999-11-20 Башева Елена Матвеевна Способ получения вытяжки из медицинских пиявок и средство с ее использованием
NO20013182L (no) 2000-06-26 2001-12-27 Nokian Tyres Plc System og fremgangsmåte for konvertering og overföring av driftsdata for dekk
RU2268739C2 (ru) * 2004-01-05 2006-01-27 ООО НВФ "Гируд И.Н." Лечебный гель "пиявит+" на основе биологически активных веществ, продуцируемых медицинской пиявкой, и способ его получения
US7795205B2 (en) * 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2487600A (en) * 1945-10-09 1949-11-08 Sharp & Dohme Inc Aqueous thixotropic gel composition
US3027229A (en) * 1957-12-02 1962-03-27 Diamond Lab Method of preparing hydrated calcium phosphate gels
US2987600A (en) * 1959-03-11 1961-06-06 Corning Glass Works Capacitor edge sealing
CA1340646C (en) * 1987-05-21 1999-07-13 John L. Krstenansky Cyclic anticoagulant peptides
US5204323B1 (en) * 1988-10-06 1995-07-18 Ciba Geigy Corp Hirudin antidotal compositions and methods
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
US5118790A (en) * 1990-07-24 1992-06-02 Sri International Analogs of hirudin
US5344644A (en) * 1991-08-01 1994-09-06 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release

Also Published As

Publication number Publication date
HU9400458D0 (en) 1994-05-30
CN1108137A (zh) 1995-09-13
ZA941087B (en) 1994-08-18
PH30338A (en) 1997-04-02
PT624375E (pt) 2002-08-30
GB9303275D0 (en) 1993-04-07
DE69430458D1 (de) 2002-05-29
DK0624375T3 (da) 2002-07-29
IL108610A0 (en) 1994-08-26
HUT66079A (en) 1994-09-28
NO940551L (h) 1994-08-19
NO940551D0 (no) 1994-02-17
EP0624375A2 (en) 1994-11-17
IL108610A (en) 1998-03-10
FI940726A0 (fi) 1994-02-16
FI940726L (fi) 1994-08-19
ES2176222T3 (es) 2002-12-01
JP3649343B2 (ja) 2005-05-18
US5472938A (en) 1995-12-05
JPH06256214A (ja) 1994-09-13
AU5508394A (en) 1994-08-25
DE69430458T2 (de) 2002-11-21
EP0624375A3 (en) 1995-07-19
FI940726A7 (fi) 1994-08-19
EP0624375B1 (en) 2002-04-24
NZ250895A (en) 1994-06-27
CA2115815A1 (en) 1994-08-19
MX9401244A (es) 1994-08-31
AU675471B2 (en) 1997-02-06
TW315303B (h) 1997-09-11

Similar Documents

Publication Publication Date Title
MX9204229A (es) Trifluorometilbencilfosfonatos utiles en el tratamiento de osteoporosis.
MX9202413A (es) Composiciones acuosas de citrato de calcio.
ES8600051A1 (es) Procedimiento de obtencion de composiciones farmaceuticas a base de derivados de acido glicirretinico.
AU532296B2 (en) Triamterene comppositions
ATE216586T1 (de) Hirudin enthaltende arzneimittel
DK0710071T3 (da) Højkoncentrerede faste mepiquatchloridprodukter
DE69518342D1 (de) Hirudin enthaltende stabilisierte, trockene Pulver
AU1506692A (en) Pharmaceutical compositions
IL77188A (en) Pharmaceutical compositions containing hpa23 for the treatment of acquired immune deficiency syndrome and analogous syndromes
ATE68973T1 (de) Mittel zur prophylaxe des herzinfarkts und zur verhuetung des reinfarkts.
HUP9901183A2 (hu) Készítmények és eljárások az orális mukozitisz megakadályozására és kezelésére
GR3030026T3 (en) Stabilised pharmaceutical compositions containing dobutamine
MX9800032A (es) Mezclas fungicidas.
ZA965687B (en) Inhibited pickling acids containing chloride and zinc ions.
ITVR930071A0 (it) Procedimento per la registrazione e/o il controllo di operazioni succedentisi nel tempo in ambienti di tipo industriale.
IT8822479A0 (it) Sale di calcio biodisponibile e relative composizoni farmaceutiche.
ITRM930493A0 (it) Metodologia per la neutralizzazione di disinfettanti.
IT1248094B (it) Complessi costituiti da principi oftalmici basici ed acido tannico

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner